164 related articles for article (PubMed ID: 29560115)
1. Inverse expression of survivin and reprimo correlates with poor patient prognosis in gastric cancer.
Cerda-Opazo P; Valenzuela-Valderrama M; Wichmann I; Rodríguez A; Contreras-Reyes D; Fernández EA; Carrasco-Aviño G; Corvalán AH; Quest AFG
Oncotarget; 2018 Feb; 9(16):12853-12867. PubMed ID: 29560115
[TBL] [Abstract][Full Text] [Related]
2. DNA damage-inducible gene, reprimo functions as a tumor suppressor and is suppressed by promoter methylation in gastric cancer.
Ooki A; Yamashita K; Yamaguchi K; Mondal A; Nishimiya H; Watanabe M
Mol Cancer Res; 2013 Nov; 11(11):1362-74. PubMed ID: 23982217
[TBL] [Abstract][Full Text] [Related]
3. Loss of Reprimo and S100A2 expression in human gastric adenocarcinoma.
Luo J; Zhu Y; Yang G; Gong L; Wang B; Liu H
Diagn Cytopathol; 2011 Oct; 39(10):752-7. PubMed ID: 20949468
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of Reprimo in lung cancer.
Suzuki M; Shigematsu H; Takahashi T; Shivapurkar N; Sathyanarayana UG; Iizasa T; Fujisawa T; Gazdar AF
Lung Cancer; 2005 Mar; 47(3):309-14. PubMed ID: 15713514
[TBL] [Abstract][Full Text] [Related]
5. Implication of Reprimo and hMLH1 gene methylation in early diagnosis of gastric carcinoma.
Liu L; Yang X
Int J Clin Exp Pathol; 2015; 8(11):14977-82. PubMed ID: 26823831
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of Reprimo correlates with genetic instability and predicts poor prognosis in pancreatic ductal adenocarcinoma.
Sato N; Fukushima N; Matsubayashi H; Iacobuzio-Donahue CA; Yeo CJ; Goggins M
Cancer; 2006 Jul; 107(2):251-7. PubMed ID: 16752411
[TBL] [Abstract][Full Text] [Related]
7. Studying the expression rate and methylation of Reprimo gene in the blood of patients suffering from gastric cancer.
Abbasi A; Heydari S
Eur J Transl Myol; 2018 Apr; 28(2):7423. PubMed ID: 29991989
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of Reprimo in human malignancies.
Takahashi T; Suzuki M; Shigematsu H; Shivapurkar N; Echebiri C; Nomura M; Stastny V; Augustus M; Wu CW; Wistuba II; Meltzer SJ; Gazdar AF
Int J Cancer; 2005 Jul; 115(4):503-10. PubMed ID: 15700311
[TBL] [Abstract][Full Text] [Related]
9. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma.
Song KY; Jung CK; Park WS; Park CH
Jpn J Clin Oncol; 2009 May; 39(5):290-6. PubMed ID: 19336448
[TBL] [Abstract][Full Text] [Related]
10. Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells.
Cao W; Fan R; Wang L; Cheng S; Li H; Jiang J; Geng M; Jin Y; Wu Y
Tumour Biol; 2013 Apr; 34(2):963-71. PubMed ID: 23264087
[TBL] [Abstract][Full Text] [Related]
11. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis.
Chen P; Zhu J; Liu DY; Li HY; Xu N; Hou M
Med Oncol; 2014 Jan; 31(1):775. PubMed ID: 24338338
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium.
Malhotra U; Zaidi AH; Kosovec JE; Kasi PM; Komatsu Y; Rotoloni CL; Davison JM; R C; Irvin ; Hoppo T; Nason KS; Kelly LA; Gibson MK; Jobe BA
PLoS One; 2013; 8(11):e78343. PubMed ID: 24223792
[TBL] [Abstract][Full Text] [Related]
14. Impact of liver kinase B1 on p53 and survivin and its correlation with prognosis in gastric cancer.
Li W; Luo S; Ma G; Wang L
Onco Targets Ther; 2019; 12():1439-1445. PubMed ID: 30863111
[TBL] [Abstract][Full Text] [Related]
15. Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression.
Hamilton JP; Sato F; Jin Z; Greenwald BD; Ito T; Mori Y; Paun BC; Kan T; Cheng Y; Wang S; Yang J; Abraham JM; Meltzer SJ
Clin Cancer Res; 2006 Nov; 12(22):6637-42. PubMed ID: 17121882
[TBL] [Abstract][Full Text] [Related]
16. Reprimo as a potential biomarker for early detection in gastric cancer.
Bernal C; Aguayo F; Villarroel C; Vargas M; Díaz I; Ossandon FJ; Santibáñez E; Palma M; Aravena E; Barrientos C; Corvalan AH
Clin Cancer Res; 2008 Oct; 14(19):6264-9. PubMed ID: 18829507
[TBL] [Abstract][Full Text] [Related]
17. The antagonistic effect between STAT1 and Survivin and its clinical significance in gastric cancer.
Deng H; Zhen H; Fu Z; Huang X; Zhou H; Liu L
Oncol Lett; 2012 Jan; 3(1):193-199. PubMed ID: 22740880
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of βIII-tubulin and survivin associated with drug resistance to docetaxel-based chemotherapy in advanced gastric cancer.
Zheng WE; Chen H; Yuan SF; Wu LL; Zhang W; Sun HY; Chen WJ
J BUON; 2012; 17(2):284-90. PubMed ID: 22740207
[TBL] [Abstract][Full Text] [Related]
19. Roles of β-catenin, TCF-4, and survivin in nasopharyngeal carcinoma: correlation with clinicopathological features and prognostic significance.
Jin PY; Zheng ZH; Lu HJ; Yan J; Zheng GH; Zheng YL; Wu DM; Lu J
Cancer Cell Int; 2019; 19():48. PubMed ID: 30867651
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.
Augello C; Caruso L; Maggioni M; Donadon M; Montorsi M; Santambrogio R; Torzilli G; Vaira V; Pellegrini C; Roncalli M; Coggi G; Bosari S
BMC Cancer; 2009 Apr; 9():125. PubMed ID: 19397802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]